These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 4317702)
41. [The treatment of eosinophilic and chromophobe adenomas of the pituitary gland with radioactive yttrium implants]. Dogliotti GC; Molinatti GM Minerva Med; 1967 Dec; 58(99):4528-9. PubMed ID: 4295508 [No Abstract] [Full Text] [Related]
42. Absence of chromophobe adenomas from a large series of pituitary tumors. McCormick WF; Halmi NS Arch Pathol; 1971 Oct; 92(4):231-8. PubMed ID: 4106152 [No Abstract] [Full Text] [Related]
43. [Current status of the treatment of pituitary adenomas]. Pîrvu V Neurol Psihiatr Neurochir; 1966; 11(2):181-6. PubMed ID: 4292027 [No Abstract] [Full Text] [Related]
44. Prognosis of pituitary adenomas with arteriographic abnormal vascularization. Roth DA; Ferris EJ; Tomiyasu U J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):535-40. PubMed ID: 5122381 [TBL] [Abstract][Full Text] [Related]
45. [FREQUENCY OF THE ABO GROUP IN HYPOPHYSIAL ADENOMAS]. IRACI G; TOFFOLO GG Tumori; 1964; 50():469-72. PubMed ID: 14261596 [No Abstract] [Full Text] [Related]
46. Metrizamide cisternography in the evaluation of pituitary adenomas and the empty sella syndrome. Gross CE; Binet EF; Esguerra JV J Neurosurg; 1979 Apr; 50(4):472-6. PubMed ID: 581770 [No Abstract] [Full Text] [Related]
47. [Empty sella turcica syndrome. Comments with report of a case]. Diaz Fernández AJ; Shum C; Merchante Iglesias A; Vila Canella T; Colomé Pavón JA; de Pablo Martínez MI Rev Clin Esp; 1975 Oct; 139(2):179-82. PubMed ID: 172986 [No Abstract] [Full Text] [Related]